DR. JAMES L WELLS M.D. NPI 1164509873

NPI Details

DR. James L, Wells, M.D. is a hematology and oncology internal medicine in West Columbia, SC with 21 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. James L, Wells, M.D. NPI is 1164509873. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL UNIVERSITY OF SOUTH CAROLINA COLLEGE OF MEDICINE
Graduation Year:2005

The provider's business location address is:

222 E MEDICAL LN STE 400
WEST COLUMBIA, SC
ZIP 29169-848
Phone: (803) 794-7511
Fax: (803) 794-7751

The NPI 1164509873 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, ferric carboxymaltose, 1 mg (HCPCS:J1439)
• Injection, fosaprepitant, 1 mg (HCPCS:J1453)
• Injection, nivolumab, 1 mg (HCPCS:J9299)
• Injection, denosumab, 1 mg (HCPCS:J0897)
• Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml (HCPCS:Q9967)
• Injection, pembrolizumab, 1 mg (HCPCS:J9271)
• Injection, oxaliplatin, 0.5 mg (HCPCS:J9263)
• Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS:J9144)
• Injection, paclitaxel, 1 mg (HCPCS:J9267)
• Injection, docetaxel, 1 mg (HCPCS:J9171)
• Injection, bortezomib (velcade), 0.1 mg (HCPCS:J9041)
• Injection, dexamethasone sodium phosphate, 1 mg (HCPCS:J1100)
• Injection, granisetron hydrochloride, 100 mcg (HCPCS:J1626)
• Injection, atropine sulfate, 0.01 mg (HCPCS:J0461)
• Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units (HCPCS:Q5106)
• Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg (HCPCS:Q5117)
• Injection, palonosetron hcl, 25 mcg (HCPCS:J2469)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Injection, bevacizumab, 10 mg (HCPCS:J9035)
• Blood test, basic group of blood chemicals (calcium, total) (HCPCS:80048)
• Injection, rituximab, 10 mg (HCPCS:J9312)
• Liver function blood test panel (HCPCS:80076)
• Injection, pegfilgrastim, excludes biosimilar, 0.5 mg (HCPCS:J2506)
• Injection, epoetin alfa, (for non-esrd use), 1000 units (HCPCS:J0885)
• Injection, fluorouracil, 500 mg (HCPCS:J9190)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Administration of chemotherapy into vein, 1 hour or less (HCPCS:96413)
• Injection, irinotecan, 20 mg (HCPCS:J9206)
• Injection of additional new drug or substance into vein (HCPCS:96375)
• Injection, etoposide, 10 mg (HCPCS:J9181)
• Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg (HCPCS:J9201)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Cyclophosphamide, 100 mg (HCPCS:J9070)
• Infusion, normal saline solution, sterile (500 ml = 1 unit) (HCPCS:J7040)
• Injection, carboplatin, 50 mg (HCPCS:J9045)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Injection, potassium chloride, per 2 meq (HCPCS:J3480)
• Magnesium level (HCPCS:83735)
• Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less (HCPCS:96367)
• Leuprolide acetate (for depot suspension), 7.5 mg (HCPCS:J9217)
• Injection, doxorubicin hydrochloride, 10 mg (HCPCS:J9000)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Nuclear medicine study from skull base to mid-thigh with ct scan (HCPCS:78815)
• Lactate dehydrogenase (enzyme) level (HCPCS:83615)
• Injection, leucovorin calcium, per 50 mg (HCPCS:J0640)
• Infusion, normal saline solution , 1000 cc (HCPCS:J7030)
• Administration of additional new drug or substance into vein, 1 hour or less (HCPCS:96417)
• Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96401)
• Injection, magnesium sulfate, per 500 mg (HCPCS:J3475)
• Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries (HCPCS:A9552)
• Blood test, thyroid stimulating hormone (tsh) (HCPCS:84443)
• Thyroxine (thyroid chemical), free (HCPCS:84439)
• Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less (HCPCS:96365)
• Carcinoembryonic antigen (cea) protein level (HCPCS:82378)
• Ct scan of chest with contrast (HCPCS:71260)
• Ferritin (blood protein) level (HCPCS:82728)
• Ct scan of abdomen and pelvis with contrast (HCPCS:74177)
• Administration of chemotherapy into vein, each additional hour (HCPCS:96415)
• Infusion, normal saline solution, 250 cc (HCPCS:J7050)
• Administration of additional new drug or substance into vein using push technique (HCPCS:96411)
• Injection, zoledronic acid, 1 mg (HCPCS:J3489)
• Iron level (HCPCS:83540)
• Iron binding capacity (HCPCS:83550)
• Adrenocorticotropic hormone (acth) level (HCPCS:82024)
• Psa (prostate specific antigen) measurement, total (HCPCS:84153)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Administration of prolonged chemotherapy into vein (HCPCS:96416)
• Infusion into a vein for therapy, prevention, or diagnosis, each additional hour (HCPCS:96366)
• Infusion into a vein for hydration, 31-60 minutes (HCPCS:96360)
• Application of on-body injector for under skin injection (HCPCS:96377)
• Infusion into a vein for therapy, prevention, or diagnosis concurrent with another infusion (HCPCS:96368)
• Established patient office or other outpatient visit, 40-54 minutes (HCPCS:99215)
• Automated urinalysis test (HCPCS:81003)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 19-9 (HCPCS:86301)
• Piflufolastat f-18, diagnostic, 1 millicurie (HCPCS:A9595)
• Blood creatinine level (HCPCS:82565)
• Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 (HCPCS:86300)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• Administration of hormonal anti-neoplastic chemotherapy under skin or into muscle (HCPCS:96402)
• Ct scan of chest without contrast (HCPCS:71250)
• New patient office or other outpatient visit, 60-74 minutes (HCPCS:99205)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Injection, diphenhydramine hcl, up to 50 mg (HCPCS:J1200)
• Infusion into a vein for hydration, each additional hour (HCPCS:96361)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• Follow-up hospital inpatient care per day, typically 15 minutes (HCPCS:99231)
• Administration of chemotherapy into vein using push technique (HCPCS:96409)
• Ct scan of abdomen and pelvis without contrast (HCPCS:74176)
• Injection of drug or substance into vein (HCPCS:96374)
• Irrigation of implanted venous access drug delivery device (HCPCS:96523)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Ct scan of soft tissue of neck with contrast (HCPCS:70491)

The enumeration date for this NPI number is 11/1/2006 and was last updated on 11/11/2020.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available: